 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 May 1995 | Volume 122 Issue 9 | Pages 689-700
Purpose: To review the pharmacology, electrophysiology, and toxicity of amiodarone and to discuss the clinical results produced when amiodarone is used as therapy for patients with atrial fibrillation, patients with nonsustained ventricular tachycardia and cardiomyopathy, patients who have recently had myocardial infarctions, and patients who have survived out-of-hospital cardiac arrest caused by ventricular tachycardia or ventricular fibrillation.
Data Sources: Animal and clinical studies involving the pharmacology and electrophysiology of amiodarone and clinical trials in which amiodarone was used as therapy for the arrhythmias noted above were reviewed.
Study Selection: Relevant studies that reported on the efficacy and toxicity of amiodarone and on long-term therapy using amiodarone were reviewed, and their data were summarized. Reports of ongoing trials using amiodarone were also reviewed and summarized.
Results: Amiodarone is useful for the treatment of many rhythm disturbances. Although side effects from this agent are common, serious toxicity necessitating discontinuation of therapy is infrequent. Unlike other antiarrhythmic agents, amiodarone has not been shown to increase mortality in any population studied.
Conclusion: Amiodarone, a unique antiarrhythmic agent with many pharmacologic actions, is effective in the treatment of a wide range of rhythm abnormalities. Several large, randomized trials will provide further information about the clinical usefulness of this agent.
Author and Article Information
From Boston University School of Medicine, Boston, Massachusetts.
DIAGNOSIS AND TREATMENT
Amiodarone: Reevaluation of an Old Drug
Requests for Reprints: Philip J. Podrid, MD, Section of Cardiology, University Hospital, 88 East Newton Street, Boston, MA 02118.
This article has been cited by other articles:
|
|
 |
|
  W. L Baker and C M. White Post-Cardiothoracic Surgery Atrial Fibrillation: A Review of Preventive Strategies Ann. Pharmacother., April 1, 2007; 41(4): 587 - 598. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. E. Lim, H.-N. Pak, J. C. Ahn, W. H. Song, and Y.-H. Kim Torsade de pointes induced by short-term oral amiodarone therapy Europace, December 1, 2006; 8(12): 1051 - 1053. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Brantman and J. Howie Use of Amiodarone to Prevent Atrial Fibrillation After Cardiac Surgery Crit. Care Nurse, February 1, 2006; 26(1): 48 - 58. [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Aasbo, A. T. Lawrence, K. Krishnan, M. H. Kim, and R. G. Trohman Amiodarone Prophylaxis Reduces Major Cardiovascular Morbidity and Length of Stay after Cardiac Surgery: A Meta-Analysis Ann Intern Med, September 6, 2005; 143(5): 327 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Teng, T. C. Sarich, U. G. Eriksson, J. E. Hamer, S. Gillette, K.-M. Schutzer, G. F. Carlson Jr, and P. R. Kowey A Pharmacokinetic Study of the Combined Administration of Amiodarone and Ximelagatran, an Oral Direct Thrombin Inhibitor J. Clin. Pharmacol., September 1, 2004; 44(9): 1063 - 1071. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Calvert and J. Brown Influence of Antiarrhythmia Therapy on Survival Times of 19 Clinically Healthy Doberman Pinschers With Dilated Cardiomyopathy That Experienced Syncope, Ventricular Tachycardia, and Sudden Death (1985-1998) J. Am. Anim. Hosp. Assoc., January 1, 2004; 40(1): 24 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ikegami, T. Shiga, T. Tsushima, T. Nirei, and H. Kasanuki Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Induced by Amiodarone: A Report on Two Cases Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2002; 7(1): 25 - 28. [Abstract] [PDF]
|
|
|
|
 |
|
 I. Biran and I. Steiner Coital headaches induced by amiodarone Neurology, February 12, 2002; 58(3): 501 - 502. [Full Text] [PDF]
|
|
|
|
|
|
M. Naganuma, T. Shiga, K. Nishikata, T. Tsuchiya, H. Kasanuki, and E. Fujii Role of Desethylamiodarone in the Anticoagulant Effect of Concurrent Amiodarone and Warfarin Therapy Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2001; 6(4): 363 - 367. [Abstract] [PDF]
|
|
|
|
 |
|
 S.G. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, A.J. Camm, R. Cappato, S.M. Cobbe, C. Di Mario, et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology Eur. Heart J., August 2, 2001; 22(16): 1374 - 1450. [PDF]
|
|
|
|
 |
|
 G. H. Daniels Amiodarone-Induced Thyrotoxicosis J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 3 - 8. [Full Text]
|
|
|
|
 |
|
 M. J. P. Raatikainen, T. E. Morey, P. Druzgala, P. Milner, M. D. Gonzalez, and D. M. Dennis Potent and Reversible Effects of ATI-2001 on Atrial and Atrioventricular Nodal Electrophysiological Properties in Guinea Pig Isolated Perfused Heart J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 779 - 785. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. L Waldo ELECTROPHYSIOLOGY: Treatment of atrial flutter Heart, August 1, 2000; 84(2): 227 - 227. [Full Text] [PDF]
|
|
|
|
|
|
A Capucci, G.Q Villani, D Aschieri, A Rosi, and M.F Piepoli Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation Eur. Heart J., January 1, 2000; 21(1): 66 - 73. [Abstract] [PDF]
|
|
|
|
|
|
G. Cotter, A. Blatt, E. Kaluski, E. Metzkor-Cotter, M. Koren, I. Litinski, R. Simantov, Y. Moshkovitz, R. Zaidenstein, E. Peleg, et al. Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study Eur. Heart J., December 2, 1999; 20(24): 1833 - 1842. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Odeh, E. Schiff, and A. Oliven Hyponatremia During Therapy With Amiodarone Arch Intern Med, November 22, 1999; 159(21): 2599 - 2600. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Catherwood, W. D. Fitzpatrick, M. L. Greenberg, P. T. Holzberger, D. J. Malenka, B. R. Gerling, and J. D. Birkmeyer Cost-Effectiveness of Cardioversion and Antiarrhythmic Therapy in Nonvalvular Atrial Fibrillation Ann Intern Med, April 20, 1999; 130(8): 625 - 636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. Bosch, G.-R. Li, R. Gaspo, and S. Nattel Electrophysiologic Effects of Chronic Amiodarone Therapy and Hypothyroidism, Alone and in Combination, on Guinea Pig Ventricular Myocytes J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 156 - 165. [Abstract] [Full Text]
|
|
|
|
|
|
M. H. Eckman, R. H. Falk, and S. G. Pauker Cost-effectiveness of Therapies for Patients With Nonvalvular Atrial Fibrillation Arch Intern Med, August 10, 1998; 158(15): 1669 - 1677. [Abstract] [Full Text]
|
|
|
|
|
|
C M Newman, A Price, D W Davies, T A Gray, and A P Weetman Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy Heart, February 1, 1998; 79(2): 121 - 127. [Full Text]
|
|
|
|
 |
|
 I. Sim, K. M. McDonald, P. W. Lavori, C. M. Norbutas, and M. A. Hlatky Quantitative Overview of Randomized Trials of Amiodarone to Prevent Sudden Cardiac Death Circulation, November 4, 1997; 96(9): 2823 - 2829. [Abstract] [Full Text]
|
|
|
|
 |
|
 I. Dimopoulou, K. Marathias, M. Daganou, S. Prapas, G. Stavridis, M. Khoury, S. Geroulanos, and D. V. Cokkinos LOW-DOSE AMIODARONE-RELATED COMPLICATIONS AFTER CARDIAC OPERATIONS J. Thorac. Cardiovasc. Surg., July 1, 1997; 114(1): 31 - 37. [Abstract] [Full Text]
|
|
|
|
 |
|
 I. Kodama, K. Kamiya, and J. Toyama Cellular electropharmacology of amiodarone Cardiovasc Res, July 1, 1997; 35(1): 13 - 29. [Full Text] [PDF]
|
|
|
|
 |
|
 C. H. Hennekens, C. M. Albert, S. L. Godfried, J. M. Gaziano, and J. E. Buring Adjunctive Drug Therapy of Acute Myocardial Infarction -- Evidence from Clinical Trials N. Engl. J. Med., November 28, 1996; 335(22): 1660 - 1668. [Full Text] [PDF]
|
|
|
|
|
|
B. M. Massie, S. G. Fisher, P. C. Deedwania, B. N. Singh, R. D. Fletcher, and S. N. Singh Effect of Amiodarone on Clinical Status and Left Ventricular Function in Patients With Congestive Heart Failure Circulation, June 15, 1996; 93(12): 2128 - 2134. [Abstract] [Full Text]
|
|
|
|
|
|
M. J. Silver, J. Young, E. J. Topol, A. Colli, L. A. Sechi, S. De Carli, E. Bartoli, S. N. Singh, R. D. Fletcher, and S. G. Fisher Amiodarone in Congestive Heart Failure N. Engl. J. Med., December 14, 1995; 333(24): 1639 - 1641. [Full Text]
|
|
Article
